ZYXI Quote, Financials, Valuation and Earnings

Intelligent Bio Solutions, Inc. has a net margin of -321.21% compared to Zynex, Inc.'s net margin of -269.38%. Zynex, Inc.'s return on equity of -709.17% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.

Zynex, Inc. has a consensus price target of $3.70, signalling upside risk potential of 218.97%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 1632.1%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Zynex, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Zynex, Inc..

Zynex, Inc. has a beta of 0.987, which suggesting that the stock is 1.301% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Zynex, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zynex, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.

Zynex, Inc. quarterly revenues are $13.4M, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Zynex, Inc.'s net income of -$42.9M is lower than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Zynex, Inc.'s price-to-earnings ratio is 18.60x while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zynex, Inc. is 0.33x versus 1.38x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Standard BioTools, Inc. has a net margin of -321.21% compared to Zynex, Inc.'s net margin of -162.05%. Zynex, Inc.'s return on equity of -709.17% beat Standard BioTools, Inc.'s return on equity of -24.44%.

Zynex, Inc. has a consensus price target of $3.70, signalling upside risk potential of 218.97%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 7.64%. Given that Zynex, Inc. has higher upside potential than Standard BioTools, Inc., analysts believe Zynex, Inc. is more attractive than Standard BioTools, Inc..

Zynex, Inc. has a beta of 0.987, which suggesting that the stock is 1.301% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.

Zynex, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zynex, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

Zynex, Inc. quarterly revenues are $13.4M, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. Zynex, Inc.'s net income of -$42.9M is lower than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Zynex, Inc.'s price-to-earnings ratio is 18.60x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zynex, Inc. is 0.33x versus 4.24x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

LENSAR, Inc. has a net margin of -321.21% compared to Zynex, Inc.'s net margin of -25.94%. Zynex, Inc.'s return on equity of -709.17% beat LENSAR, Inc.'s return on equity of -1013.45%.

Zynex, Inc. has a consensus price target of $3.70, signalling upside risk potential of 218.97%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 42.99%. Given that Zynex, Inc. has higher upside potential than LENSAR, Inc., analysts believe Zynex, Inc. is more attractive than LENSAR, Inc..

Zynex, Inc. has a beta of 0.987, which suggesting that the stock is 1.301% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.

Zynex, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zynex, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.

Zynex, Inc. quarterly revenues are $13.4M, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. Zynex, Inc.'s net income of -$42.9M is lower than LENSAR, Inc.'s net income of -$3.7M. Notably, Zynex, Inc.'s price-to-earnings ratio is 18.60x while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zynex, Inc. is 0.33x versus 2.10x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Yijia Group Corp. has a net margin of -321.21% compared to Zynex, Inc.'s net margin of -44.56%. Zynex, Inc.'s return on equity of -709.17% beat Yijia Group Corp.'s return on equity of 62.15%.

Zynex, Inc. has a consensus price target of $3.70, signalling upside risk potential of 218.97%. On the other hand Yijia Group Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Zynex, Inc. has higher upside potential than Yijia Group Corp., analysts believe Zynex, Inc. is more attractive than Yijia Group Corp..

Zynex, Inc. has a beta of 0.987, which suggesting that the stock is 1.301% less volatile than S&P 500. In comparison Yijia Group Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Zynex, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Yijia Group Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zynex, Inc. pays -- of its earnings as a dividend. Yijia Group Corp. pays out -- of its earnings as a dividend.

Zynex, Inc. quarterly revenues are $13.4M, which are larger than Yijia Group Corp. quarterly revenues of $103.9K. Zynex, Inc.'s net income of -$42.9M is lower than Yijia Group Corp.'s net income of -$46.3K. Notably, Zynex, Inc.'s price-to-earnings ratio is 18.60x while Yijia Group Corp.'s PE ratio is 46.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zynex, Inc. is 0.33x versus 15.15x for Yijia Group Corp.. Usually stocks with elevated PS ratios are considered overvalued.